Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000950103-25-014793
Filing Date
2025-11-14
Accepted
2025-11-14 17:26:19
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 12929
2 EXHIBIT A dp237439_ex99a.htm EX-99.A 8642
  Complete submission text file 0000950103-25-014793.txt   22988
Mailing Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209
Business Address 1812 NORTH MOORE ST, SUITE 1705 ARLINGTON VA 22209 571-389-6000
Evolent Health, Inc. (Subject) CIK: 0001628908 (see all company filings)

EIN.: 320454912 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-89390 | Film No.: 251488335
SIC: 8741 Services-Management Services
(CF Office: 07 Trade & Services)

Mailing Address 1215 5TH AVE N, NASHVILLE TN 37208
Business Address
Boehler Adam (Filed by) CIK: 0001982325 (see all company filings)

Type: SCHEDULE 13G